MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 210 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $37,655 | -99.8% | 1,133,828 | +43.4% | 0.02% | +40.0% |
Q3 2022 | $24,937,000 | +1326.6% | 790,899 | +1276.3% | 0.02% | +1400.0% |
Q2 2022 | $1,748,000 | +181.5% | 57,464 | +88.8% | 0.00% | – |
Q4 2021 | $621,000 | -88.1% | 30,434 | -88.8% | 0.00% | -100.0% |
Q3 2021 | $5,224,000 | -41.3% | 271,542 | -32.3% | 0.00% | -40.0% |
Q2 2021 | $8,901,000 | +0.6% | 401,287 | +19.0% | 0.01% | -16.7% |
Q1 2021 | $8,852,000 | +9.1% | 337,231 | -22.3% | 0.01% | 0.0% |
Q4 2020 | $8,111,000 | +3056.0% | 433,988 | +2764.6% | 0.01% | – |
Q3 2020 | $257,000 | -98.4% | 15,150 | -97.8% | 0.00% | -100.0% |
Q2 2020 | $15,866,000 | +61.7% | 681,224 | -41.7% | 0.02% | 0.0% |
Q1 2020 | $9,814,000 | +516.1% | 1,168,385 | +616.8% | 0.02% | +1000.0% |
Q4 2019 | $1,593,000 | +477.2% | 163,011 | +459.9% | 0.00% | – |
Q3 2019 | $276,000 | -43.0% | 29,114 | +6.0% | 0.00% | -100.0% |
Q1 2019 | $484,000 | +12.3% | 27,456 | +10.6% | 0.00% | 0.0% |
Q4 2018 | $431,000 | -89.5% | 24,830 | -91.0% | 0.00% | -80.0% |
Q3 2018 | $4,113,000 | -41.7% | 276,023 | -37.8% | 0.01% | -44.4% |
Q2 2018 | $7,056,000 | -40.8% | 443,768 | -47.1% | 0.01% | -43.8% |
Q1 2018 | $11,922,000 | -24.9% | 839,609 | -25.9% | 0.02% | -27.3% |
Q4 2017 | $15,873,000 | +51.8% | 1,133,765 | +55.0% | 0.02% | +37.5% |
Q3 2017 | $10,458,000 | +97.9% | 731,335 | +118.0% | 0.02% | +77.8% |
Q2 2017 | $5,285,000 | +794.2% | 335,533 | +994.8% | 0.01% | +800.0% |
Q3 2016 | $591,000 | -83.3% | 30,648 | -85.2% | 0.00% | -85.7% |
Q3 2015 | $3,540,000 | -47.3% | 207,015 | -42.6% | 0.01% | -46.2% |
Q2 2015 | $6,721,000 | -24.8% | 360,568 | -23.0% | 0.01% | -23.5% |
Q1 2015 | $8,938,000 | -6.1% | 468,457 | -19.0% | 0.02% | -15.0% |
Q4 2014 | $9,523,000 | +74.6% | 578,583 | +87.6% | 0.02% | +42.9% |
Q3 2014 | $5,455,000 | +126.4% | 308,366 | +164.2% | 0.01% | +100.0% |
Q2 2014 | $2,409,000 | +141.6% | 116,726 | +155.2% | 0.01% | +133.3% |
Q1 2014 | $997,000 | +252.3% | 45,733 | +329.0% | 0.00% | +200.0% |
Q4 2013 | $283,000 | -64.4% | 10,660 | -68.3% | 0.00% | -66.7% |
Q3 2013 | $794,000 | +46.8% | 33,603 | +33.6% | 0.00% | +50.0% |
Q2 2013 | $541,000 | – | 25,157 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |